Aspergillosis in children after liver transplantation: Single center experience

Pediatric Transplantation

Volumn 11, Issue 8, 2007, Pages 868-875

  Teisseyre, Joanna ^a   Kaliciński, Piotr ^a   Markiewicz Kijewska, Małgorzata ^a   Szymczak, Marek ^a   Ismail, Hor ^a   Drewniak, Tomasz ^a   Nachulewicz, Paweł ^a   Broniszczak, Dorota ^a   Teisseyre, Mikołaj ^a   Pawłowska, Joanna ^a   Garczewska, Barbara ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Aspergillosis; Children; Fungal infections; Liver transplantation; Risk factors; Treatment

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; CYCLOSPORIN; DACLIZUMAB; FLUCONAZOLE; FLUCYTOSINE; FUNGUS ANTIGEN; GALACTOMANNAN; GANCICLOVIR; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIGEN DETECTION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BACTERIAL INFECTION; CAUSE OF DEATH; CHILD; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FUNGUS IDENTIFICATION; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LAPAROTOMY; LENGTH OF STAY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRIC SURGERY; POLYPHARMACY; POSTOPERATIVE INFECTION; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SUPERINFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; LIVER; LIVER TRANSPLANTATION; MALE; POLAND; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 35748984657     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00754.x     Document Type: Article

References (38)

1. Mizuta M, Blumberg EA. Impact of fungal infections on solid organ transplant recipients. Clin Microbiol Newsl 2005 : 27 : 123 126.
2. Verma A, Wade JJ, Cheeseman P, et al. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant 2005 : 9 : 220 225.
3. Pappas PG, Andes D, Schuster M, et al. Invasive fungal infections in low-risk liver transplant recipients: A multi-center prospective observational study. Am J Transplant 2006 : 6 : 386 391.
4. Latge JP. Aspergillus fumigatus and Aspergillosis. Clin Microbiol Rev 1999 : 12 : 310 350.
5. Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in 1990s. Transplantation 1997 : 15 : 716 720.
6. Minari A, Husni R, Avery RK, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002 : 4 : 195 200.
7. Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003 : 36 : 46 52.
8. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005 : 18 : 44 69.
9. Zaoutis TE, Heydon K, Chu JH, et al. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006 : 117 : 711 716.
10. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program. Med Mycol 2005 : 43 : s49 s58.
11. Fortun J, Davila PM, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002 : 8 : 1065 1070.
12. Gavalda J, Len O, San Juan R, et al. Risk factors for invasive aspergillosis in solid organ transplant recipients: A case control study. Clin Infect Dis 2005 : 41 : 52 59.
13. Ergin F, Arslan H, Azap A, et al. Invasive aspergillosis in solid organ transplantation: Report of eight cases and review of literature. Transpl Int 2003 : 16 : 280 286.
14. Selby R, Ramirez CB, Singh R, et al. Brain abscess in solid organ recipients receiving cyclosporine based immunosuppresion. Arch Surg 1997 : 132 : 304 311.
15. Marin P, Garcia-Martos P, Garcia-Doncel A, et al. Endocarditis by Aspergillus fumigatus in a renal transplant. Mycopathologia 1999 : 145 : 127 129.
16. Kaneko J, Sugawara Y, Makuuchi M. Aspergillus osteomyelitis after liver transplantation. Liver Transpl 2002 : 8 : 1073 1075.
17. Hunt KE, Glasgow BJ. Aspergillus endophtalmitis. An unrecognized endemic disease in orthotopic liver transplantation. Ophthalmology 1996 : 103 : 61 62.
18. Enzenauer RW, Calderwood S, Levin AV. Screening for fungal endophtalmitis in children at risk. Pediatrics 1992 : 90 : 451 457.
19. Matsuo T, Nakagawa H, Matsuo N. Endogenous Aspergillus endophtalmitis associated with periodontitis. Ophtalmologica 1995 : 209 : 109 111.
20. Papanicolaou GA, Meyers BR, Fuchs WS. Infectious ocular complications in orthotopic liver transplant patients. Clin Infect Dis 1997 : 24 : 1172 1177.
21. Teisseyre J, Kalicinski P, Kaminski A. Successful treatment of endogenous Aspergillus endophtalmitis in 21 year-old woman after orthotopic liver transplantation. Acta Bio Medica Ateneo Parmense 2004 : 75 suppl2 : 25 29.
22. Fortun J, Martin-Davila P, Alvarez ME, et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001 : 71 : 145 149.
23. Verweij PE, Dompeling EC, Donnelly JP, et al. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997 : 25 : 86 89.
24. Kwak E, Husain S, Obman A, et al. Efficacy of galactomannan antigen using Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004 : 42 : 435 438.
25. Obayashi T, Yoshida M, Goto H, et al. Plasma (1->3)- beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995 : 345 : 17 20.
26. Loeffler J, Kloepfer K, Hebart H, et al. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis. J Infect Dis 2002 : 185 : 1203 1206.
27. Lass-Flörl K, Gunsilius E, Gastl G, et al. Diagnosing of Invasive Aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 2004 : 42 : 4154 4157.
28. Singh N. Invasive mycoses in organ transplant recipients: Controversies in prophylaxis and management. J Antimicrob Chemother 2000 : 45 : 749 755.
29. Fortun J, Martin-Davila P, Moreno S, et al. Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high risk patients. J Microb Chemother 2003 : 52 : 813 819.
30. Fisher NC, Singhal S, Miller SJ, et al. Fungal infection and liposomal amphotericinB (Ambisome) therapy in liver transplantation: A 2 year review. J Antimicrob Chemother 1999 : 43 : 597 600.
31. Castroagudin JF, Ponton C, Bustamante M, et al. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high risk liver transplant recipients. Transplant Proc 2005 : 37 : 3965 3967.
32. Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother 2004 : 48 : 970 978.
33. Nivoix Y, Zamfir A, Lutun P, et al. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J Infect 2006 : 52 : 67 74.
34. Steinbach WJ, Singh N, Miller JL, et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant in non-transplant patients. Antimicrob Agents Chemother 2004 : 48 : 4922 4925.
35. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplantants: An international consensus. Clin Infect Dis 2002 : 34 : 7 14.
36. Kusne S, Torre-Cisneros J, Manez R. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992 : 166 : 1379 1383.
37. Singh N. The changing face of invasive aspergillosis among liver transplant recipients. Liver Transpl 2002 : 8 : 1071 1072.
38. Singh N. Treatment of opportunistic mycoses: How long is long enough? Lancet Infect Dis 2003 : 3 : 703 708.